Generated August 15, 2026.
Overview
HLTH and XLV are both healthcare-focused ETFs, but they pursue fundamentally different strategies. HLTH is an actively managed fund betting on healthcare companies deploying artificial intelligence—drug discovery, diagnostics, medical devices, and IT platforms. XLV is a passive index tracker that holds the broad S&P 500 Health Care Select Sector, offering exposure to legacy pharma, medical device giants, health insurers, and healthcare services firms without AI specialization.
How they differ
The biggest difference is strategy: HLTH is actively managed and concentrated in AI-driven healthcare businesses, while XLV passively tracks the entire healthcare sector of the S&P 500. That means HLTH carries manager risk and potential overlap with the broadest healthcare themes, while XLV offers the stability and transparency of index construction. Second, their scale and cost are inverted—XLV commands $41.9B in assets with a 0.09% expense ratio, while HLTH holds just $2.30M at 0.75%, reflecting HLTH's youth (inception July 2026) and niche strategy. Third, their sensitivity to market moves differs sharply: HLTH carries a beta of 1.086, meaning it amplifies broad market swings, while XLV's beta of 0.51 suggests it moves only half as much as the overall market—typical for a large, mature healthcare index. XLV also distributes 1.57% quarterly; HLTH reports no distribution.
Who each is best for
HLTH: Fits investors who believe AI will reshape healthcare delivery and discovery and are comfortable with active management's potential for outperformance or underperformance against the broader sector. These investors likely have a medium-to-long time horizon and higher risk tolerance.
XLV: Fits investors seeking steady, diversified healthcare exposure with minimal fees and lower volatility. Suits those who want a stable core holding in healthcare without betting on a single thematic trend or accepting active management risk.
Key risks to know
- Concentration and manager risk (HLTH): An actively managed $2.30M fund betting on AI adoption in healthcare faces the dual risk that the theme underperforms and that the manager's stock picks lag the broader sector. Active alpha is not guaranteed.
- Thematic obsolescence (HLTH): If AI's adoption in healthcare slows, faces regulatory headwinds, or disappoints relative to hype, HLTH's narrow mandate leaves little room for diversification out of that drawdown.
- Sector cyclicality (XLV): Healthcare is less cyclical than industrials, but XLV still moves with healthcare earnings cycles, FDA approval rhythms, and insurance regulation—factors that can drive sharp sector rotations independent of overall market moves.
- Index concentration (XLV): The Health Care Select Sector is dominated by a handful of mega-cap names (pharma and device leaders). A decline in those firms drags the entire index regardless of underlying healthcare demand.
Bottom line
If you're pursuing a thematic bet on AI reshaping healthcare and can tolerate the volatility and manager-selection risk of a small, actively managed fund, HLTH offers targeted exposure. If you want broad, low-cost healthcare sector access with half the market's typical volatility, XLV's size, cost, and index structure provide a simpler foundation. Past performance does not guarantee future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.